# Gossamer Bio (GOSS) — Earnings

GOSS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/goss/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$13.60 |
| EPS estimate | −$14.17 |
| EPS surprise | +4.03% |
| Revenue surprise | +112.41% |
| Revenue | $11.5M |
| Revenue estimate | $5.4M |
| Reported | Aug 5, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1728117/000172811725000068/goss-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 5, 2025 | −$14.17 | −$13.60 | 4.03% | $5.4M | $11.5M |
| Q1 2025 | May 15, 2025 | −$14.97 | −$12.80 | 14.50% | $4.1M | $9.9M |
| Q4 2024 | Mar 13, 2025 | −$13.60 | −$12.00 | 11.76% | $6.8M | $9.4M |
| Q3 2024 | Nov 7, 2024 | −$11.77 | −$11.20 | 4.86% | $8.5M | $9.5M |
| Q2 2024 | Aug 12, 2024 | $40.53 | $17.60 | -56.58% | $114.3M | $95.8M |
| Q1 2024 | May 7, 2024 | −$15.21 | −$15.20 | 0.05% | — | — |
| Q4 2023 | Mar 5, 2024 | −$16.67 | −$16.80 | -0.80% | — | — |
| Q3 2023 | Nov 9, 2023 | −$20.52 | −$16.80 | 18.11% | — | — |
| Q2 2023 | Aug 8, 2023 | −$39.14 | −$36.00 | 8.02% | — | — |
| Q1 2023 | May 9, 2023 | −$42.40 | −$41.60 | 1.89% | — | — |
| Q4 2022 | Mar 17, 2023 | −$49.84 | −$47.20 | 5.29% | — | — |
| Q3 2022 | Nov 3, 2022 | −$51.42 | −$52.00 | -1.12% | — | — |
| Q2 2022 | Aug 9, 2022 | −$55.28 | −$59.20 | -7.09% | — | — |
| Q1 2022 | May 10, 2022 | −$61.29 | −$60.80 | 0.79% | — | — |
| Q4 2021 | Mar 3, 2022 | −$60.10 | −$59.20 | 1.50% | — | — |
| Q3 2021 | Nov 8, 2021 | −$62.80 | −$64.00 | -1.91% | — | — |
| Q2 2021 | Aug 9, 2021 | −$60.64 | −$64.00 | -5.54% | — | — |
| Q1 2021 | May 6, 2021 | −$60.48 | −$62.40 | -3.17% | — | — |
| Q4 2020 | Feb 25, 2021 | −$63.20 | −$70.40 | -11.39% | — | — |
| Q3 2020 | Nov 10, 2020 | −$68.27 | −$64.00 | 6.25% | — | — |

## Frequently Asked Questions

### When did Gossamer Bio (GOSS) last report earnings?

Gossamer Bio last reported on Aug 5, 2025, covering fiscal Q2 2025.

### Did GOSS beat earnings estimates?

Yes. Gossamer Bio reported EPS of −$13.60 for Q2 2025 against a −$14.17 estimate — a 4.03% beat.

### How much revenue did GOSS report last quarter?

Gossamer Bio reported $11.5M in revenue for Q2 2025, against a consensus estimate of $5.4M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).